Cancer biomarkers: closer to delivering on their promise.
暂无分享,去创建一个
[1] Kwon-Sik Park,et al. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. , 2011, Cancer cell.
[2] H. Hager,et al. High resolution spiral CT for determining the malignant potential of solitary pulmonary nodules: refining and testing the test , 2011, Acta radiologica.
[3] G. Poste. Bring on the biomarkers , 2011, Nature.
[4] Patrick O. Brown,et al. The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection , 2009, PLoS medicine.
[5] E. Petricoin,et al. The blood peptidome: a higher dimension of information content for cancer biomarker discovery , 2006, Nature Reviews Cancer.
[6] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[7] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[8] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.